Remove 2022 Remove Documentation Remove Pharmaceutical Companies
article thumbnail

Filings buzz in pharmaceuticals: 65% increase in cloud computing mentions in Q1 of 2022

Pharmaceutical Technology

Mentions of cloud computing within the filings of companies in the pharmaceutical industry rose 65% between the final quarter of 2021 and the first quarter of 2022. To assess whether cloud computing is featuring more in the summaries and strategies of pharmaceutical companies, two measures were calculated.

article thumbnail

NICE recommends first licenced treatment for AL amyloidosis

European Pharmaceutical Review

According to the Janssen Pharmaceutical Companies of Johnson & Johnson and NICE, DVCd is recommended for the rare bone marrow disorder, only if daratumumab is stopped after 24 cycles of treatment, or earlier if the condition progresses.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients

ISPE

2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients. Tue, 11/01/2022 - 06:49. 2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients. 1 November 2022. 2022 ISPE Annual Meeting & Expo. Trudy Patterson. iSpeak Blog. Susan Sandler.

FDA 98
article thumbnail

Filings buzz in pharmaceuticals: 38% decrease in digitalization mentions in Q2 of 2022

Pharmaceutical Technology

Mentions of digitalization within the filings of companies in the pharmaceutical industry fell 38% between the first and second quarters of 2022. To assess whether digitalization is featuring more in the summaries and strategies of pharmaceutical companies, two measures were calculated. of all sentences.

article thumbnail

Filings buzz in pharmaceuticals: 22% decrease in robotics mentions in Q1 of 2022

Pharmaceutical Technology

Mentions of robotics within the filings of companies in the pharmaceutical industry fell 22% between the final quarter of 2021 and the first quarter of 2022. To assess whether robotics is featuring more in the summaries and strategies of pharmaceutical companies, two measures were calculated. of all sentences.

article thumbnail

Filings buzz in pharmaceuticals: 24% decrease in artificial intelligence mentions in Q2 of 2022

Pharmaceutical Technology

Mentions of artificial intelligence within the filings of companies in the pharmaceutical industry fell 24% between the first and second quarters of 2022. To assess whether artificial intelligence is featuring more in the summaries and strategies of pharmaceutical companies, two measures were calculated.

article thumbnail

Pharmacovigilance deep dive: risk minimisation measures

European Pharmaceutical Review

The sampling strategy must be supported by sound and properly cited sources whose conclusions must be presented as supportive elements in the study documents. The following four elements of sampling methodology were found to be under-documented in RMM effectiveness studies: Supporting documentation for country/region selection.